SCHEMBL3664521

SCHEMBL3664521

CCC(N)C1(C(=O)O)CCCC1

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 2/20 0.36
SLC6A3 Q01959 2/20 0.36
FFAR3 O14843 1/20 0.36
CYP2C19 P33261 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC1A3 P43003 1/20 0.32
SLC1A2 P43004 1/20 0.32
SLC1A1 P43005 1/20 0.32
USP2 O75604 1/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
CYP1A2 P05177 1/20 0.31
TSHR P16473 1/20 0.31
BLM P54132 1/20 0.31
CACNA2D1 P54289 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
LTA4H P09960 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5667980 0.98 SLC6A4 (0.39) SLC6A4SLC6A3FFAR3CYP2C19SLC6A2
Hydrochloric Acid SCHEMBL5665595 0.96 SLC6A4 (0.38) SLC6A4SLC6A3FFAR3CYP2C19SLC6A2
SCHEMBL3989202 0.96 FFAR3 (0.36) SLC6A4SLC6A3FFAR3CYP2C19SLC1A3
SCHEMBL1161505 0.91 FFAR3 (0.39) SLC6A4SLC6A3FFAR3SLC1A3SLC1A2
SCHEMBL14037320 0.77 CYP2C19 (0.34) FFAR3CYP2C19TSHR
SCHEMBL9972636 0.77 CYP2C19 (0.39) FFAR3CYP2C19USP2ALDH1A1LMNA
SCHEMBL17507162 0.75 CYP2C19 (0.38) FFAR3CYP2C19USP2ALDH1A1LMNA
SCHEMBL10532998 0.74 CYP2C19 (0.35) SLC6A4SLC6A3FFAR3CYP2C19SLC6A2
Hydrochloric Acid SCHEMBL1285236 0.73
SCHEMBL9935954 0.72 CYP2C19 (0.34) FFAR3CYP2C19TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2234961-A2 NOVEL CYCLIC HYDROCARBON COMPOUNDS FOR THE TREATMENT OF DISEASES LEO PHARMA A/S (DK) 2010-10-06 EP disclosed
WO-2009065406-A2 NOVEL CYCLIC HYDROCARBON COMPOUNDS FOR THE TREATMENT OF DISEASES LEO PHARMA A/S (DK) 2009-05-28 WO disclosed